Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ficara

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Nature Communications|February 16, 2018
ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activityMatteo Massara, Ornella Bonavita, Benedetta Savino, et al.
Human Gene Therapy|March 17, 2004
Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu miceSara Deola, Samantha Scaramuzza, Roberto Sciarretta Birolo, et al.
British Journal of Haematology|February 26, 2025
Iron trapping in macrophages reshapes the homeostasis of the haematopoietic systemLaura Crisafulli, Margherita Correnti, Elena Gammella, et al.
Nature Medicine|May 2, 2002
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacementAlessandro Aiuti, Sergio Vai, Alessandra Mortellaro, et al.
Haematologica|February 23, 2019
MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiationLaura Crisafulli, Sharon Muggeo, Paolo Uva, et al.
Stem Cell Reports|October 22, 2021
PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasmSharon Muggeo, Laura Crisafulli, Paolo Uva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potentialFrancesca Ficara, Daniela B Superchi, Raisa Jofra Hernández, et al.
Blood|June 23, 2012
Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implicationsVeronica Marrella, Pietro L Poliani, Elena Fontana, et al.
Science (New York, N.Y.)|June 29, 2002
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioningAlessandro Aiuti, Shimon Slavin, Memet Aker, et al.
Journal of Translational Medicine|July 14, 2007
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cellsSara Deola, Samantha Scaramuzza, Roberto Sciarretta Birolo, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Nature Communications|February 16, 2018
ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activityMatteo Massara, Ornella Bonavita, Benedetta Savino, et al.
Human Gene Therapy|March 17, 2004
Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu miceSara Deola, Samantha Scaramuzza, Roberto Sciarretta Birolo, et al.
British Journal of Haematology|February 26, 2025
Iron trapping in macrophages reshapes the homeostasis of the haematopoietic systemLaura Crisafulli, Margherita Correnti, Elena Gammella, et al.
Nature Medicine|May 2, 2002
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacementAlessandro Aiuti, Sergio Vai, Alessandra Mortellaro, et al.
Haematologica|February 23, 2019
MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiationLaura Crisafulli, Sharon Muggeo, Paolo Uva, et al.
Stem Cell Reports|October 22, 2021
PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasmSharon Muggeo, Laura Crisafulli, Paolo Uva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potentialFrancesca Ficara, Daniela B Superchi, Raisa Jofra Hernández, et al.
Blood|June 23, 2012
Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implicationsVeronica Marrella, Pietro L Poliani, Elena Fontana, et al.
Science (New York, N.Y.)|June 29, 2002
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioningAlessandro Aiuti, Shimon Slavin, Memet Aker, et al.
Journal of Translational Medicine|July 14, 2007
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cellsSara Deola, Samantha Scaramuzza, Roberto Sciarretta Birolo, et al.
Pageof 4